Cytosurge AG
Michael Gabi currently serves as the Chief Product Officer at Spacetek Technology AG, where the focus is on developing innovative time-of-flight mass spectrometers that integrate space technology into terrestrial applications. In addition to this role, Michael Gabi has been involved with Cytosurge AG since 2009 in various capacities, including Consultant and President of the Board of Directors, while also contributing as a Master Inventor and CTO. Previous experience includes an internship at Wanhua Chemical Group and part-time laboratory assistant positions at Lindenhof AG and Anawa AG. Michael Gabi holds a Dr. sc. ETH in Biomedical/Medical Engineering and a Master’s degree in Material Science from ETH Zürich, along with Matura Typus C and a qualification as a Medical/Clinical Assistant from the University Hospital Berne.
This person is not in any offices
Cytosurge AG
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting-edge solutions based on its patented FluidFM® technology. At the heart of this technology are the hollow FluidFM Probes – the Micropipette, Nanopipette, and the Nanosyringe – specifically designed to offer a wide range of unique applications for single-cell manipulation in biology research. Cytosurge's current systems compatible with FluidFM probes include the FluidFM ADD-ON for AFM systems and the standalone semi-automated FluidFM OMNIUM system. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, contributing to human well-being through advancements in single-cell technologies. As the partner of choice for precision gene engineering cell line manufacturing, Cytosurge enables next-generation biologic production and cell and gene therapy treatments, empowering people to live longer and healthier lives. Cytosurge implements advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and the manufacturing of high-precision gene-engineered cell lines. With a unique single-cell workflow and dynamic gene expression analytics, Cytosurge manufactures advanced gene-engineered cell lines, empowering next-generation treatments to benefit human well-being.